HIGH DOSE INTENSITY-MODULATED ARC THERAPY (IMAT) AS PRIMARY THERAPY FOR LYMPH NODE METASTASIZED PROSTATE CANCER: FEASIBILITY AND REPORT ON ACUTE AND LATE TOXICITY

被引：0
|
作者：
Fonteyne, V. [1 ]
Villeirs, G. [2 ]
Ost, P. [3 ]
Vandecasteele, K. [3 ]
De Neve, W. [3 ]
De Meerleer, G. [3 ]
机构：
[1] Ghent Univ Hosp, Radiat Oncol, Ghent, Belgium
[2] Univ Ziekenhuis, Dept Radiol, Ghent, Belgium
[3] Univ Ziekenhuis, Radiat Oncol, Ghent, Belgium
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1195
引用
收藏
页码：S402 / S403
页数：2
相关论文
共 50 条
  • [1] HYPOFRACTIONATED INTENSITY-MODULATED ARC THERAPY FOR LYMPH NODE METASTASIZED PROSTATE CANCER
    Fonteyne, Valerie
    De Gersem, Werner
    De Neve, Wilfried
    Jacobs, Filip
    Lumen, Nicolaas
    Vandecasteele, Katrien
    Villeirs, Geert
    De Meerleer, Gert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (04): : 1013 - 1020
  • [2] DOSE-VOLUME CHARACTERISTICS AND ACUTE TOXICTY OF HYPOFRACTIONATED INTENSITY-MODULATED ARC THERAPY (IMAT) plus ANDROGEN DEPRIVATION (AD) AS PRIMARY THERAPY FOR LYMPH NODE METASTASIZED PROSTATE CANCER.
    De Neve, W.
    Fonteyne, V.
    Villeirs, G.
    De Wagter, C.
    Jacobs, F.
    Vandecasteele, K.
    Ost, R.
    De Meerleer, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S321 - S322
  • [3] Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: Early late toxicity and 3-year clinical outcome
    Fonteyne, Valerie
    Lumen, Nicolaas
    Ost, Piet
    Van Praet, Charles
    Vandecasteele, Katrien
    Ir, Werner De Gersem
    Villeirs, Geert
    De Neve, Wilfried
    Decaestecker, Karel
    De Meerleer, Gert
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 109 (02) : 229 - 234
  • [4] High-dose intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on dosimetry aspects and acute toxicity in the Indian scenario
    De, Sandeep
    Kannan, Venkatesan
    Deshpande, Sudesh
    Anand, Vivek
    Ghadi, Yogesh
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2010, 6 (01) : 58 - 64
  • [5] Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer
    Duthoy, W
    De Gersem, W
    Vergote, K
    Boterberg, T
    Derie, C
    Smeets, P
    De Wagter, C
    De Neve, W
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03): : 794 - 806
  • [6] Planning and verification of intensity-modulated arc therapy (IMAT): A prostate case study
    Bedford, J.
    Warrington, A.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (03) : S24 - S24
  • [7] Dose-escalating Intensity Modulated Arc Therapy (RapidArc) of Prostate cancer: Acute and Late toxicity as a Function of Prostate volume
    Hentschel, B.
    Strauss, D.
    Wagner, K.
    Buth, K. -J
    Oehler, W.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 111 - 112
  • [8] Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer
    Choo, Richard
    Hillman, David W.
    Mitchell, Cecilia
    Daniels, Thomas
    Vargas, Carlos
    Rwigema, Jean Claude
    Corbin, Kimberly
    Keole, Sameer
    Vora, Sujay
    Merrell, Kenneth
    Stish, Bradley
    Pisansky, Thomas
    Davis, Brian J.
    Amundson, Adam
    Wong, William
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (05): : 1085 - 1094
  • [9] Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion
    Fonteyne, Valerie
    Villeirs, Geert
    Speleers, Bruno
    De Neve, Wilfried
    De Wagter, Carms
    Lumen, Nicolas
    De Meerleer, Gert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 799 - 807
  • [10] Optimized intensity-modulated arc therapy for prostate cancer treatment
    Ma, LJ
    Yu, CX
    Earl, M
    Holmes, T
    Sarfaraz, M
    Li, XA
    Shepard, D
    Amin, P
    DiBiase, S
    Suntharalingam, M
    Mansfield, C
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 96 (06) : 379 - 384
12345